S-Equol mitigates motivational deficits and dysregulation associated with HIV-1

S-Equol mitigates motivational deficits and dysregulation associated with HIV-1

Abstract Motivational deficits (e.g., apathy) and dysregulation (e.g., addiction) in HIV-1 seropositive individuals, despite treatment with combination antiretroviral therapy, necessitates the development of innovative adjunctive therapeutics. S-Equol (SE), a selective estrogen receptor β agonist, h...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristen A. McLaurin, Sarah J. Bertrand, Jessica M. Illenberger, Steven B. Harrod, Charles F. Mactutus, Rosemarie M. Booze
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/e54c76ad5c684d5f8c80d1bf6cbe203a
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items